Fenimore Christopher R.

Avg. Two Year Performance

No purchase track record
(3%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)(< 1%)< 1%(2%)(3%)
Sale Success Rate1 of 62 of 62 of 60 of 60 of 6

Regeneron Pharmaceuticals I...

Drugs » Biotechnology

SVP Finance & CFO:

Holdings: 24.43K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--